GLP-2 Injection Vial (5mg, 10mg, 30mg)

Price range: $149.99 through $499.99

GLP-2 is a dual GIP and GLP-1 receptor agonist selected by customers focused on appetite control, glucose metabolism and advanced body-weight support. This lyophilized vial is offered with a stated strength of 5 mg; 10 mg; 30 mg.

Choose an option to view quantity pricing.

Description

Description

Customers receive a clearly identified GLP-2 (inferred) product with third-party testing, lot-specific documentation and straightforward storage information. Formula, molecular weight, mechanism and finished-product details are organized below for easy comparison.

Potential Benefits and Product Highlights

  • Supports appetite regulation and satiety.
  • Promotes glucose-dependent insulin signaling through two incretin pathways.
  • Human trials of approved formulations show meaningful weight and glycemic benefits.
  • Dual-receptor activity offers a different metabolic profile from GLP-1-only products.
  • Independent third-party testing with lot-specific quality documentation.

Product Details

Product name GLP-2 – 5 mg / 10 mg / 30 mg
Main category Peptides
Subcategory Weight Management Peptides
Product format Lyophilized vial
Declared strength 5 mg; 10 mg; 30 mg
Active identity / composition GLP-2 (inferred)
Quality documentation Independent third-party testing and lot-specific Certificate of Analysis

Chemical Information

Preferred name GLP-2 (Tirzepatide)
Molecular formula C₂₂₅H₃₄₈N₄₈O₆₈
Molecular weight Approximately 4,813.5 g/mol
Peptide length 39 amino-acid residues
Sequence features Aib residues, modified lysine and C20 fatty-diacid-containing side chain
Structure class Lipidated synthetic incretin-receptor agonist peptide
Target class Dual GIP and GLP-1 receptor agonist
Common CAS reference 2023788-19-2
Presentations 5 mg, 10 mg and 30 mg vials
Analytical focus Sequence, modified residues, intact mass, related peptides and assay

How It Works

GLP-2 activates both GIP and GLP-1 receptors. This dual action affects appetite, insulin release, nutrient handling and metabolic signaling after meals.

Evidence note: Substantial human evidence exists for approved GLP-2 products, but results, tolerability and appropriate use require individualized professional guidance. Sources: PubChem – tirzepatide compound record; DailyMed – Mounjaro tirzepatide reference labeling; DailyMed – Zepbound tirzepatide reference labeling.

Product Strength and Usage Information

This lyophilized vial is offered with a stated strength of 5 mg; 10 mg; 30 mg. Check the current label, serving or unit information and lot-specific documentation before use.

No single dosage suits every compound, goal or customer. Use should follow the product label and appropriate professional guidance, especially for potent hormones, prescription-class ingredients and investigational compounds.

Quality and Testing

Identity, purity and finished-product content are reviewed as separate quality attributes. The lot-specific Certificate of Analysis should identify the methods, results, batch number, testing provider and test date.

  • Chromatographic testing evaluates purity and related substances.
  • Mass spectrometry supports molecular identity and expected mass.
  • Finished-product testing evaluates the supplied concentration, unit content, fill, count, uniformity or physical presentation as applicable.
  • Lot-specific documentation supports confident purchasing and product traceability.

Storage and Handling

  • Keep the sealed vial under the temperature conditions printed on the product label.
  • Protect from light, moisture and repeated temperature changes.
  • After reconstitution, follow the stated refrigeration and use-period instructions.
  • Avoid repeated freeze-thaw cycles and inspect the vial before use.

Frequently Asked Questions

What is included in this product?

GLP-2 – 5 mg / 10 mg / 30 mg supplied in a lyophilized vial with the declared composition and strength shown in the specifications.

What is GLP-2 – 5 mg / 10 mg / 30 mg?

GLP-2 is a dual GIP and GLP-1 receptor agonist selected by customers focused on appetite control, glucose metabolism and advanced body-weight support.

What potential benefits are associated with it?

Potential areas of interest include supports appetite regulation and satiety, promotes glucose-dependent insulin signaling through two incretin pathways, human trials of approved formulations show meaningful weight and glycemic benefits.

How does it work?

GLP-2 activates both GIP and GLP-1 receptors. This dual action affects appetite, insulin release, nutrient handling and metabolic signaling after meals.

How strong is the evidence?

Substantial human evidence exists for approved GLP-2 products, but results, tolerability and appropriate use require individualized professional guidance.

How is product quality documented?

Independent third-party testing and a lot-specific Certificate of Analysis provide identity, purity and finished-product information.

How should the product be stored?

Keep the product in its original container and follow the temperature, light and handling conditions shown on the label.

What should be checked when the product arrives?

Review the product name, format, strength, lot number, container integrity and matching Certificate of Analysis.